AD/PNP-FaraAMP: Phase I ongoing

PNP completed the first 3 cohorts of an open-label, U.S. Phase I trial evaluating AD/PNP-FaraAMP in about 15 patients with solid tumors, primarily head and neck tumors. The company said there were no ...